Ming-Thau Sheu Selected Research

sacchachitin

8/2023	Composite Hydrogels of Ultrasound-Assisted-Digested Formic Acid-Decellularized Extracellular Matrix and Sacchachitin Nanofibers Incorporated with Platelet-Rich Plasma for Diabetic Wound Treatment.
6/2020	A Novel Composite Hydrogel Composed of Formic Acid-Decellularized Pepsin-Soluble Extracellular Matrix Hydrogel and Sacchachitin Hydrogel as Wound Dressing to Synergistically Accelerate Diabetic Wound Healing.
1/2020	TEMPO-Oxidized Sacchachitin Nanofibers (TOSCNFs) Combined with Platelet-Rich Plasma (PRP) for Management of Dry Eye Syndrome.
1/2012	Wound-healing effect of micronized sacchachitin (mSC) nanogel on corneal epithelium.
2/2005	Development of fungal mycelia as a skin substitute: characterization of keratinocyte proliferation and matrix metalloproteinase expression during improvement in the wound-healing process.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ming-Thau Sheu Research Topics

Disease

25	Neoplasms (Cancer) 10/2023 - 10/2006
6	Wounds and Injuries (Trauma) 08/2023 - 02/2005
5	Breast Neoplasms (Breast Cancer) 01/2022 - 03/2015
4	Inflammation (Inflammations) 11/2023 - 10/2006
4	Colonic Neoplasms (Colon Cancer) 04/2022 - 01/2015
3	Adenocarcinoma 12/2021 - 09/2010
3	Osteoarthritis 04/2013 - 11/2004
3	Pain (Aches) 04/2013 - 04/2007
3	Chondrosarcoma 05/2012 - 11/2004
2	Pancreatic Neoplasms (Pancreatic Cancer) 10/2023 - 01/2023
2	Ovarian Neoplasms (Ovarian Cancer) 04/2022 - 11/2018
2	Corneal Injuries 01/2020 - 01/2012
2	Cardiotoxicity 12/2018 - 03/2015
2	Crush Injuries 10/2016 - 11/2012
2	Rupture 01/2014 - 09/2008
2	Erectile Dysfunction 11/2012 - 07/2011
1	Body Weight (Weight, Body) 11/2023
1	Obesity 11/2023
1	Cicatrix (Scar) 08/2023
1	Lymphoma (Lymphomas) 11/2022
1	Triple Negative Breast Neoplasms 04/2022
1	Bites and Stings (Sting) 01/2022
1	Cytokine Release Syndrome 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 06/2020
1	Dry Eye Syndromes (Dry Eye Syndrome) 01/2020
1	Leukemia 01/2017

Drug/Important Bio-Agent (IBA)

9	HydrogelsIBA 08/2023 - 04/2007
5	sacchachitinIBA 08/2023 - 02/2005
5	Docetaxel (Taxotere)FDA Link 01/2022 - 07/2016
4	LecithinsIBA 10/2023 - 01/2016
4	AntigensIBA 11/2022 - 10/2007
4	monomethoxypolyethylene glycol (MPEG)IBA 01/2022 - 11/2018
4	SolutionsIBA 01/2019 - 09/2008
4	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2018 - 01/2015
3	AntibodiesIBA 01/2022 - 01/2021
3	Hyaluronic Acid (Hyaluronan)IBA 10/2021 - 04/2013
3	Saline SolutionIBA 10/2016 - 11/2012
2	Therapeutic UsesIBA 10/2023 - 03/2013
2	Paclitaxel (Taxol)FDA LinkGeneric 10/2023 - 01/2021
2	formic acid (formate)IBA 08/2023 - 06/2020
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2023 - 12/2021
2	Cisplatin (Platino)FDA LinkGeneric 04/2022 - 11/2018
2	liposomal doxorubicin (Doxil)FDA Link 12/2021 - 03/2015
2	Matrix Metalloproteinases (MMPs)IBA 09/2021 - 02/2005
2	Bispecific AntibodiesIBA 01/2021 - 11/2018
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2008
2	Messenger RNA (mRNA)IBA 01/2017 - 08/2008
2	MicellesIBA 07/2016 - 01/2016
2	TabletsIBA 01/2014 - 09/2008
2	Ethanol (Ethyl Alcohol)IBA 03/2013 - 06/2008
1	IronIBA 11/2023
1	Hormones (Hormone)IBA 11/2023
1	HepcidinsIBA 11/2023
1	Gemcitabine FDA Link 10/2023
1	Eosine Yellowish-(YS) (Eosin)IBA 08/2023
1	Decellularized Extracellular MatrixIBA 08/2023
1	Hematoxylin (Haematoxylon)IBA 08/2023
1	Sirolimus (Rapamycin)FDA Link 01/2023
1	VaccinesIBA 11/2022
1	OligodeoxyribonucleotidesIBA 11/2022
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 11/2022
1	OVA-8IBA 11/2022
1	InterferonsIBA 11/2022
1	Cancer VaccinesIBA 11/2022
1	PlatinumIBA 04/2022
1	2- (1H- indazol- 4- yl)- 6- (4- methanesulfonylpiperazin- 1- ylmethyl)- 4- morpholin- 4- ylthieno(3,2- d)pyrimidineIBA 01/2022
1	human ERBB2 proteinIBA 01/2022
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2022
1	EpitopesIBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	Liposomes (Liposome)IBA 12/2021
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 12/2021
1	Hyaluronan SynthasesIBA 10/2021
1	carfilzomibIBA 01/2021
1	Human Serum Albumin FDA LinkGeneric 01/2021
1	dibenzheptropineIBA 06/2020
1	Histamine Antagonists (Antihistamines)IBA 06/2020
1	Pepsin A (Pepsin)IBA 06/2020
1	TEMPOIBA 01/2020
1	ChitosanIBA 01/2020
1	Benzalkonium Compounds (Benzalkonium Chloride)FDA LinkGeneric 01/2020
1	Trastuzumab (Herceptin)FDA Link 01/2019
1	Poloxamer (Poloxamer 407)IBA 11/2018
1	Small Interfering RNA (siRNA)IBA 01/2017
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2017
1	Tyrosine (L-Tyrosine)FDA Link 01/2017
1	LigandsIBA 01/2017
1	DisulfidesIBA 01/2017
1	Cysteine (L-Cysteine)FDA Link 01/2017
1	Platelet-Derived Growth FactorIBA 10/2016
1	platelet-derived growth factor ABIBA 10/2016
1	QuercetinIBA 01/2016
1	2',3',4',5'- tetrahydroxystilbene- 2- O- beta- D- glucosideIBA 03/2015

Therapy/Procedure

9	Therapeutics 10/2023 - 03/2013
8	Injections 11/2021 - 10/2007
5	Drug Therapy (Chemotherapy) 10/2023 - 07/2016
2	Immunotherapy 11/2022 - 01/2022
2	Tooth Extraction (Tooth Extractions) 01/2012 - 04/2007
1	Heterologous Transplantation (Xenotransplantation) 10/2021
1	Intravenous Administration 12/2018